[Cost-benefits of vaccination against hepatitis B in hospital personnel in Venezuela].
A cost-benefit study for hepatitis B vaccination in Venezuelan hospital workers was performed through a decision tree analysis model, which includes the probabilities for the different outcomes of the hepatitis B virus infection (HBV). The current average cost of HBV infection to the Venezuelan Government was estimated at US$ 1,759 per patient. Implementation of selective vaccination or a mass vaccination campaign for the hospital workers would reduce the total cost of HBV infection to 51% or 28%, respectively, saving $17 to $26 million. This type of economic analysis may influence the distribution of the resources to be allocated for the control of HBV infection in Venezuela.
Fernández Barboza
R
R
Ministerio de Sanidad y Asistencia Social de Venezuela, Departamento de Vigilancia Epidemiológica, Caracas.
Rivero
D
D
Echeverría
B
B
Machado
I V
IV
D002353:Carrier State / Q000453:epidemiology; D003663:Decision Trees; D004469:Economics, Hospital; D006509:Hepatitis B / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control*; D017325:Hepatitis B Vaccines; D006801:Humans; D008962:Models, Theoretical; D009313:National Health Programs / Q000191:economics; D010564:Personnel, Hospital; D015995:Prevalence; D014611:Vaccination / Q000191:economics*; D014687:Venezuela / Q000453:epidemiology; D014761:Viral Hepatitis Vaccines
D017325:Hepatitis B Vaccines; D014761:Viral Hepatitis Vaccines
Costo-beneficio de la vacunación contra la hepatitis B en trabajadores de hospitales de Venezuela.